Eeva Rainio
PhD
erainio@utu.fi +358 29 450 2653 +358 40 746 1861 Kiinamyllynkatu 10 Turku |
cell and molecular biology; cell signalling; protein kinases; phosphorylation; proteomics; cancer biology
Intracellular signalling regulated by Pim kinases.
- Design Thinking in Healthcare Education (2023) Design Thinking in Healthcare: From Problem to Innovative Solutions Hajduk Isabella, Nordberg Annika, Rainio Eeva
- Design Thinking in Healthcare: From Problem to Innovative Solutions (2023) Pakarinen Anni, Lemström Thomas, Rainio Eeva, Siirala Eriikka
- PIM1 accelerates prostate cancer cell motility by phosphorylating actin capping proteins (2020)
- Cell Communication and Signaling
- Jobitti 2018-2020 – mitä, miksi ja miten? (2019)
- Solubiologi
- Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion (2019)
- Cell Communication and Signaling
- The PIM1 kinase promotes prostate cancer cell migration and adhesion via multiple signalling pathways (2016)
- Experimental Cell Research
- Tricyclic Benzo[cd]azulenes Selectively Inhibit Activities of Pim Kinases and Restrict Growth of Epstein-Barr Virus-Transformed Cells (2013)
- PLoS ONE
- Enrichment and sequencing of phosphopeptides on indium tin oxide coated glass slides (2011)
- Molecular BioSystems
- Data combination from multiple matrix-assisted laser desorption/ionization (MALDI) matrices: opportunities and limitations for MALDI analysis (2010)
- Rapid Communications in Mass Spectrometry
- Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion (2010)
- Molecular Cancer
- Quantitative proteomics analysis of the nuclear fraction of human CD4+ cells in the early phases of IL-4-induced Th2 differentiation (2010)
- Molecular and Cellular Proteomics
- KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA (2009)
- PLoS Pathogens
- Pim-1 Kinase Expression Predicts Radiation Response in Squamocellular Carcinoma of Head and Neck and Is under the Control of Epidermal Growth Factor Receptor (2009)
- Neoplasia
- Oncogenic Pim family kinases as potential drug targets (2007)
- Scandinavian Journal of Immunology
- Oncogenic Pim family kinases as potential drug targets (2006)
- European Journal of Pharmaceutical Sciences
- Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity (2005)
- Virology
- Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase (2002)
- Journal of Immunology
- Pim-1 kinase and p100 cooperate to enhance c-myb activity (1998)
- Molecular Cell
UTU Research Portal